Skip to content

Automated Telephone Monitoring for Symptom Management

Automated Telephone Monitoring for Symptom Management

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00799084
Acronym
ATSM
Enrollment
526
Registered
2008-11-27
Start date
2003-04-30
Completion date
2006-11-30
Last updated
2011-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carcinoma

Keywords

symptom management, cancer, chemotherapy treatment, Behavioral Research, Physiological Effects of Drugs, Clinical Trial, Phase II

Brief summary

To improve the management of symptoms, patients with cancer undergoing chemotherapy will be monitored using an automated telephone system to record the severity of 15 prevalent symptoms for up to 8 consecutive weeks. Outcomes include; significant reduction in symptom severity and improvement in health states.

Detailed description

Overview: Prevalent symptoms among patients undergoing chemotherapy include: pain, fatigue, dry mouth, constipation, anorexia, nausea, sleep disturbance, shortness of breath or difficulty breathing, as well as psychological symptoms such as depression and anxiety. A survey of 1000 patients with cancer indicated that close to a quarter reported 10-12 symptoms. Given the impact of symptoms upon physical function, work, emotional distress, and hospitalizations, it is critical that strategies be developed and tested to improve symptom management. This trial of a behavioural intervention for symptom management is significant because: 1) it contrasts a proactive approach, individualized to patients' symptom management needs, with a more conventional model that places responsibility on the patient for symptom management; 2) it controls for the method of delivery and the use of printed material; 3) it targets prevalent symptoms known to affect cancer patients undergoing chemotherapy; 4) it examines the relative effects of each arm, in terms of symptom severity (primary outcome), impact on patients' physical and social roles, and emotional distress; and 5) it explores these outcomes in terms of their impact on the use of services and costs of care. Goal: The goal of this randomized trial is to determine if a nurse delivered Patient Assisted Management of Symptoms (PAMS) intervention individualized to patients' needs for symptom management, delivered by telephone, when compared to Telephone Information and Monitoring of Symptoms (TIMS) where symptoms are only monitored by telephone, with references to the symptom management toolkit will reduce symptom severity, improve physical function, and other outcomes.

Interventions

BEHAVIORALNurse

Receives 6 telephone calls over 8 weeks from an oncology nurse to assist with symptom management

BEHAVIORALAVR

Receives 6 telephone calls over 8 weeks from an programmed automated telephone system to assist with symptom management

Sponsors

Michigan State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 21 years of age or older * solid tumor cancer diagnosis * receiving chemotherapy treatment

Exclusion criteria

* Emotional or psychology disorder for which patient is receiving treatment * does not speak English * does not have access to a telephone * difficulty hearing on the telephone

Design outcomes

Primary

MeasureTime frame
Lower reported mean severity index among 7 prevalent symptoms9 weeks, 15 weeks

Secondary

MeasureTime frame
Reduced impact of physical role performance, improved social functioning, and reduced emotional distress; improved levels of communication between patients and providers; and improved patient satisfaction with care.9 weeks, 15 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026